Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia.

Schizophrenia research - 1 Jul 2007

Dickerson Faith, Stallings Cassie, Origoni Andrea, Boronow John, Yolken Robert

Abstract excerpt

OBJECTIVES: We investigated the association between serum levels of C-reactive protein (CRP), a marker of inflammation, and the severity of psychopathology and cognitive impairment in schizophrenia. METHODS: We measured the levels of CRP in N=413 individuals with schizophrenia. Symptom severity was evaluated with the Positive and Negative Syndrome Scale (PANSS) and cognitive functioning with the Repeatable...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Viral
Share to C-Reactive Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cognition Disorders

Share to Herpesvirus 1, Human

Share to Lymphotoxin-alpha

Share to Psychiatric Status Rating Scales

Share to Psychotic Disorders

Share to Schizophrenic Psychology

Source

Identifiers

PMID: 17490859
DOI: 10.1016/j.schres.2007.03.022

Genes

CRP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia.PMID 17490859Read ↗

Elevated C-Reactive Protein Associated With Late- and Very-Late-Onset Schizophrenia in the General Population: A Prospective StudySemantic proximity Read ↗

Joint evaluation of serum C-Reactive Protein levels and polygenic risk scores as risk factors for schizophrenia.Semantic proximity Read ↗

An Update on Promising Biomarkers in SchizophreniaSemantic proximity Read ↗

Associations of Systemic Inflammation and Senescent Cell Biomarkers with Clinical Outcomes in Older Adults with SchizophreniaSemantic proximity Read ↗

Mitochondrial Dysfunction and Cognitive Impairment in Schizophrenia: The Role of InflammationSemantic proximity Read ↗

The relationship between TLR4/NF-κB/IL-1β signaling, cognitive impairment, and white-matter integrity in patients with stable chronic schizophreniaSemantic proximity Read ↗

Association of blood levels of C-reactive protein with clinical phenotypes in Arab schizophrenic patients.Semantic proximity Read ↗

Neuro-Immune Aspects of Schizophrenia with Severe Negative Symptoms: New Diagnostic Markers of Disease Phenotype.Semantic proximity Read ↗

Tumor necrosis factor-alpha -1031T/C polymorphism is associated with cognitive deficits in chronic schizophrenia patients versus healthy controls.Semantic proximity Read ↗

Genetic association study reveals impact of interleukin 10 polymorphisms on cognitive functions in schizophrenia.Semantic proximity Read ↗

Genetic variants of the inflammatory C-reactive protein and schizophrenia in Armenian population: a pilot study.Semantic proximity Read ↗

Relationship between renal function and cognitive impairment in patients with stable schizophrenia: A multicenter cross-sectional studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.